This market grew faster than 95.6% of comparable agency NAICS markets
+25.3%Agency median −53.2%
The agency comparison covers 509 comparable NAICS markets.
Federal Capture Intelligence
Top DoD in-vitro diagnostic substance manufacturing contractors (NAICS 325413)
Contract actions: October 1, 2021 – October 23, 2026
Updated October 24, 2026 Department of Defense agency guide
NAICS 325413 · In-Vitro Diagnostic Substance Manufacturing
- Latest 12 months
- $48.0M
- Net obligations · Up $9.7M vs. $38.3M preceding
- Prime contractors
- 97
- With positive obligations in the latest 12 months
Research the DoD federal contracting market for in-vitro diagnostic substance manufacturing under NAICS 325413. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, and contract types, competition, and procurement methods.
Contract obligation trends for In-Vitro Diagnostic Substance Manufacturing at the Department of Defense
Federal records show $5.4B in net obligations across 3,531 awards in In-Vitro Diagnostic Substance Manufacturing at the Department of Defense from Oct 1, 2021 through Oct 23, 2026. This market accounts for 0.24% of $2.3T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 25.3% from $38.3M to $48.0M. 20 prime contractors accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY27 is year-to-date through Oct 23, 2026; earlier years show complete fiscal-year totals.
FY27 year-to-date: $0 versus $245K through the same date in FY26 (−100.0%).
Net obligations · complete fiscal yearNet obligations · FY27 YTDContract actions
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $4.8B | 1,660 | Complete |
| FY2023 | $547.3M | 1,330 | Complete |
| FY2024 | $50.3M | 1,253 | Complete |
| FY2025 | $48.8M | 1,323 | Complete |
| FY2026 | $48.3M | 747 | Complete |
Market at a glance
All reported prime contract awards- All-period net obligations
- $5.4B
- 3,531 awards · 220 prime contractors
- Latest 12-month movement
- +25.3%
- $48.0M vs. $38.3M
- Leading eight prime share
- 50.2%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 0.24% of $2.3T in agency-wide net obligations.
- Set-aside share when reported
- 2.4% of 2,274 awards with reported set-aside status.
- Set-aside reporting
- 55 set aside · 2,219 no set-aside · 1,257 not reported
What changed in the last 12 months?
Oct 24, 2025–Oct 23, 2026, compared with Oct 24, 2024–Oct 23, 2025.
Market structure
Competitive shifts
ABBOTT MOLECULAR INC. climbed the most in the contractor rankings
#51→#12Up 39 places
The contractor accounts for 3.2% of positive obligations across 2 reported actions.
HOLOGIC SALES AND SERVICE, LLC gained the most market share
4.09%→7.94%+3.9 percentage points
The contractor now ranks #2 by positive obligations, based on 22 reported actions.
ORTHO-CLINICAL DIAGNOSTICS, INC lost the most market share
2.6%→0.5%−2.1 percentage points
The contractor now ranks #35 by positive obligations, based on 5 reported actions.
Buyer demand
Reported obligations through AMC MADIGAN LEWIS - MM increased
$1.6M→$4.9M+$3.3M
Latest-period activity spans 26 awards across 16 prime contractors.
Reported obligations through 88TH MDSS SGSL - PA decreased
$3.6M→$671K−$3.0M
Latest-period activity spans 11 awards across 5 prime contractors.
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Federal contract obligations by funding office
See how positive obligations were attributed across funding offices in the 12 months ending Oct 23, 2026.
18.5% of positive obligations were attributed to AMC BAMC FSH - MM. That represents $8.9M, up $13.4M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- AMC BAMC FSH - MM18.5% · $8.9M · up $13.4M
- AMC MADIGAN LEWIS - MM10.2% · $4.9M · up $3.3M
- AMC TRIPLER SHAFTER - MM7.0% · $3.4M · up $1.4M
- AMC BEAUMONT BLISS - MM5.2% · $2.5M · up $649K
- ACH BENNING - MM4.5% · $2.2M · up $266K
- All other reported offices54.5% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
AMC BAMC FSH - MM
#1New to the positive-obligation rankingLatest 12 months
$8.9M
18.5% of positive obligations
Versus preceding 12 months
+$13.4M
21 active prime contractors · 23 awards
View office comparison and evidence
Reported obligations moved from $4.6M in net deobligations to $8.9M in net obligations. The office’s share of positive obligations moved from 0% to 18.5%, a change of +18.5 percentage points.
The latest period contains 53 actions across 23 awards and 2 newly active prime contractors. The preceding period contained 22 active prime contractors and 36 awards.
Leading award-level changes
- ROCHE DIAGNOSTICS CORPORATION · PIID W81K0025FA207+$1.7M: $0 → $1.7M
- ROCHE DIAGNOSTICS CORPORATION · PIID W81K0020P0371+$1.7M: −$1.7M → $0
Reported funding office
AMC MADIGAN LEWIS - MM
#2Up 6 from #8Latest 12 months
$4.9M
10.2% of positive obligations
Versus preceding 12 months
+$3.3M
16 active prime contractors · 26 awards
View office comparison and evidence
Reported obligations increased 201.7% from $1.6M to $4.9M. The office’s share of positive obligations moved from 3.7% to 10.2%, a change of +6.5 percentage points.
The latest period contains 56 actions across 26 awards and 5 newly active prime contractors. The preceding period contained 14 active prime contractors and 22 awards.
Reported funding office
AMC TRIPLER SHAFTER - MM
#3Up 1 from #4Latest 12 months
$3.4M
7.0% of positive obligations
Versus preceding 12 months
+$1.4M
11 active prime contractors · 11 awards
View office comparison and evidence
Reported obligations increased 68.9% from $2.0M to $3.4M. The office’s share of positive obligations moved from 4.5% to 7.0%, a change of +2.5 percentage points.
The latest period contains 34 actions across 11 awards. The preceding period contained 16 active prime contractors and 23 awards.
Reported funding office
AMC BEAUMONT BLISS - MM
#4Up 3 from #7Latest 12 months
$2.5M
5.2% of positive obligations
Versus preceding 12 months
+$649K
7 active prime contractors · 7 awards
View office comparison and evidence
Reported obligations increased 35.0% from $1.9M to $2.5M. The office’s share of positive obligations moved from 4.2% to 5.2%, a change of +1.0 percentage points.
The latest period contains 10 actions across 7 awards. The preceding period contained 10 active prime contractors and 12 awards.
Reported funding office
ACH BENNING - MM
#5Up 1 from #6Latest 12 months
$2.2M
4.5% of positive obligations
Versus preceding 12 months
+$266K
7 active prime contractors · 8 awards
View office comparison and evidence
Reported obligations increased 13.9% from $1.9M to $2.2M. The office’s share of positive obligations moved from 4.3% to 4.5%, a change of +0.2 percentage points.
The latest period contains 14 actions across 8 awards. The preceding period contained 11 active prime contractors and 17 awards.
Reported funding office
LANDSTUHL RMC - MM
#6Up 4 from #10Latest 12 months
$2.1M
4.4% of positive obligations
Versus preceding 12 months
+$660K
6 active prime contractors · 8 awards
View office comparison and evidence
Reported obligations increased 45.0% from $1.5M to $2.1M. The office’s share of positive obligations moved from 3.3% to 4.4%, a change of +1.1 percentage points.
The latest period contains 26 actions across 8 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 10 awards.
Reported funding office
ACH BRIAN ALLGOOD - PA
#7New to the positive-obligation rankingLatest 12 months
$1.5M
3.1% of positive obligations
Versus preceding 12 months
+$2.2M
11 active prime contractors · 15 awards
View office comparison and evidence
Reported obligations moved from $682K in net deobligations to $1.5M in net obligations. The office’s share of positive obligations moved from 0% to 3.1%, a change of +3.1 percentage points.
The latest period contains 42 actions across 15 awards and 1 newly active prime contractor. The preceding period contained 12 active prime contractors and 22 awards.
Reported funding office
AHC MONCRIEF JACKSON - MM
#8Up 6 from #14Latest 12 months
$1.5M
3.1% of positive obligations
Versus preceding 12 months
+$405K
5 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations increased 37.2% from $1.1M to $1.5M. The office’s share of positive obligations moved from 2.5% to 3.1%, a change of +0.6 percentage points.
The latest period contains 7 actions across 5 awards. The preceding period contained 5 active prime contractors and 6 awards.
Reported funding office
AMC GORDON - PA
#9Up 4 from #13Latest 12 months
$1.4M
2.9% of positive obligations
Versus preceding 12 months
+$263K
6 active prime contractors · 6 awards
View office comparison and evidence
Reported obligations increased 23.6% from $1.1M to $1.4M. The office’s share of positive obligations moved from 2.5% to 2.9%, a change of +0.3 percentage points.
The latest period contains 8 actions across 6 awards. The preceding period contained 7 active prime contractors and 9 awards.
Reported funding office
59TH MLRS SGSKS - MM
#10Up 1 from #11Latest 12 months
$1.1M
2.3% of positive obligations
Versus preceding 12 months
−$289K
4 active prime contractors · 28 awards
View office comparison and evidence
Reported obligations decreased 20.5% from $1.4M to $1.1M. The office’s share of positive obligations moved from 3.2% to 2.3%, a change of −0.9 percentage points.
The latest period contains 28 actions across 28 awards. The preceding period contained 4 active prime contractors and 30 awards.
Reported funding office
NAVMEDCEN CAMP LEJEUNE NC - MM
#15New to the positive-obligation rankingLatest 12 months
$960K
2.0% of positive obligations
Versus preceding 12 months
+$960K
2 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations rose from $0 to $960K. The office’s share of positive obligations moved from 0% to 2.0%, a change of +2.0 percentage points.
The latest period contains 5 actions across 3 awards. The preceding period contained 2 active prime contractors and 3 awards.
Reported funding office
88TH MDSS SGSL - PA
#19Down 17 from #2Latest 12 months
$671K
1.4% of positive obligations
Versus preceding 12 months
−$3.0M
5 active prime contractors · 11 awards
View office comparison and evidence
Reported obligations decreased 81.6% from $3.6M to $671K. The office’s share of positive obligations moved from 8.3% to 1.4%, a change of −6.9 percentage points.
The latest period contains 11 actions across 11 awards. The preceding period contained 6 active prime contractors and 28 awards.
Reported funding office
88TH MDSS SGSL - MM
#43Down 31 from #12Latest 12 months
$177K
0.37% of positive obligations
Versus preceding 12 months
−$1.1M
2 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations decreased 86.2% from $1.3M to $177K. The office’s share of positive obligations moved from 2.9% to 0.37%, a change of −2.5 percentage points.
The latest period contains 3 actions across 3 awards and 1 newly active prime contractor. The preceding period contained 7 active prime contractors and 23 awards.
Reported funding office
AMC BEAUMONT BLISS - PB
#46Down 41 from #5Latest 12 months
$122K
0.25% of positive obligations
Versus preceding 12 months
−$1.8M
2 active prime contractors · 2 awards
View office comparison and evidence
Reported obligations decreased 93.6% from $1.9M to $122K. The office’s share of positive obligations moved from 4.4% to 0.25%, a change of −4.1 percentage points.
The latest period contains 2 actions across 2 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 6 awards.
Reported funding office
W40M MRC0 WEST
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$4.8M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $4.8M to $0. The office’s share of positive obligations moved from 10.9% to 0%, a change of −10.9 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 14 active prime contractors and 15 awards.
Leading award-level changes
- BIOFIRE DIAGNOSTICS LLC · PIID W81K0020P0348−$933K: $933K → $0
- ROCHE DIAGNOSTICS CORPORATION · PIID W81K0023P0198−$841K: $841K → $0
Reported funding office
W2DN BROOKE AMC
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$2.6M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $2.6M to $0. The office’s share of positive obligations moved from 6.0% to 0%, a change of −6.0 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 1 active prime contractor and 2 awards.
Contract types, competition, and procurement methods
From Oct 24, 2025 through Oct 23, 2026, 429 awards had positive obligations totaling $48.5M. Simplified Acquisition was the leading reported procedure, accounting for 73.7% of positive obligations. Awards with a reported parent IDV accounted for 38.8%.
- Leading award type
- 48.6%
- Purchase Order
- Leading reported procedure
- 73.7%
- Simplified Acquisition
- Reported parent IDV
- 38.8%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 339 of 429 awards reported offers
Buying method changes
Compared with Oct 24, 2024–Oct 23, 2025. Based on 429 current awards and 756 preceding awards with positive net obligations.
- Median positive award obligations
- $33K
- Up from $13K in the preceding period
How to read these changes
Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.
Same-NAICS comparison
Compared with the NAICS 325413 peer median, parent-IDV obligation share is 39.0 percentage points lower, reported full-and-open obligation share is 2.9 percentage points lower, delivery-order obligation share is 14.1 percentage points lower, and median positive award obligations are 32.5% lower.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 38.8% | 77.8% | -39.0 pts |
| Reported full-and-open obligation share | 10.0% | 12.9% | -2.9 pts |
| Delivery-order obligation share | 29.4% | 43.5% | -14.1 pts |
| Median positive award obligations | $33K | $49K | -32.5% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
- Department of Agriculture (USDA)
- Department of Health and Human Services (HHS)
- Department of Veterans Affairs (VA)
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Purchase Order(B) | 246 | $23.6M | 48.6% |
| Delivery Order(C) | 99 | $14.3M | 29.4% |
| Definitive Contract(D) | 21 | $6.1M | 12.6% |
| BPA Call(A) | 63 | $4.5M | 9.4% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 90 | $14.0M | 28.8% |
| BPA(E) | 63 | $4.5M | 9.4% |
| FSS(C) | 9 | $327K | 0.67% |
| Not reported | 267 | $29.7M | 61.2% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 153 | $18.5M | 38.1% |
| Multiple Award(M) | 9 | $327K | 0.67% |
| Not reported | 267 | $29.7M | 61.2% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Simplified Acquisition(SP1) | 351 | $35.8M | 73.7% |
| Only One Source(SSS) | 31 | $6.8M | 14.0% |
| Negotiated Proposal/Quote(NP) | 16 | $4.6M | 9.6% |
| Sp1(SIMPLIFIED ACQUISITION) | 20 | $859K | 1.8% |
| Subject to Multiple Award Fair Opportunity(MAFO) | 9 | $327K | 0.67% |
| Np(NEGOTIATED PROPOSAL/QUOTE) | 1 | $109K | 0.22% |
| Other reported values | 1 | $30K | 0.061% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Competed Under SAP(F) | 246 | $20.3M | 41.8% |
| Not Competed Under SAP(G) | 105 | $15.5M | 31.9% |
| Not Competed(C) | 31 | $6.8M | 14.0% |
| Full and Open Competition(A) | 24 | $4.8M | 10.0% |
| G(NOT COMPETED UNDER SAP) | 5 | $580K | 1.2% |
| F(COMPETED UNDER SAP) | 15 | $279K | 0.58% |
| Other reported values | 3 | $255K | 0.53% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source - Other(ONE) | 6 | $203K | 0.42% |
| Fair Opportunity Given(FAIR) | 3 | $124K | 0.26% |
| Not reported | 420 | $48.2M | 99.3% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| SAP Non-Competition (FAR 13)(SP2) | 107 | $13.6M | 28.1% |
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 29 | $6.7M | 13.8% |
| Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH) | 3 | $2.4M | 5.0% |
| Brand Name Description (FAR 6.302-1(C))(BND) | 3 | $191K | 0.39% |
| Unique Source (FAR 6.302-1(B)(1))(UNQ) | 1 | $73K | 0.15% |
| Not reported | 286 | $25.5M | 52.6% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 407 | $47.5M | 98.0% |
| J(FIRM FIXED PRICE) | 22 | $997K | 2.0% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550) | 333 | $35.7M | 73.5% |
| Medical and Surgical Instruments, Equipment, and Supplies(6515) | 32 | $4.5M | 9.3% |
| Drugs and Biologicals(6505) | 14 | $4.5M | 9.2% |
| Laboratory Equipment and Supplies(6640) | 26 | $2.0M | 4.0% |
| Lease or Rental of Equipment- Medical, Dental, and Veterinary Equipment and Supplies(W065) | 2 | $562K | 1.2% |
| Chemical Analysis Instruments(6630) | 2 | $527K | 1.1% |
| Other reported values | 20 | $872K | 1.8% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Department of the Army(2100) | 131 | $26.7M | 55.0% |
| Defense Health Agency(97DH) | 135 | $18.5M | 38.0% |
| Department of the Air Force(5700) | 24 | $1.4M | 2.8% |
| Defense Logistics Agency(97AS) | 112 | $1.1M | 2.3% |
| Department of the Navy(1700) | 27 | $911K | 1.9% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| W40m Mrc0 West(W81K00) | 78 | $20.2M | 41.6% |
| Defense Health Agency Hcd West(HT9410) | 58 | $10.3M | 21.3% |
| Defense Health Agency(HT9406) | 20 | $3.6M | 7.4% |
| W40m Mrco Pacific(W81K02) | 21 | $3.0M | 6.2% |
| W40m Usa Hca(W81K04) | 23 | $1.9M | 3.9% |
| W40m Mrco East(W91YTZ) | 9 | $1.6M | 3.3% |
| Other reported values | 220 | $7.9M | 16.3% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| W81K0225DA021(9700) | 1 | $1.9M | 4.0% |
| W81K0025DA002(9700) | 1 | $1.7M | 3.6% |
| W9114F24D0005(9700) | 2 | $1.6M | 3.3% |
| W81K0023D0005(9700) | 1 | $1.1M | 2.2% |
| SPE8EQ25D0004(9700) | 7 | $1.0M | 2.1% |
| W81K0225DA010(9700) | 1 | $968K | 2.0% |
| HT001425A0006(9700) | 1 | $868K | 1.8% |
| N6264523D5013(9700) | 7 | $830K | 1.7% |
| Other reported values | 141 | $8.8M | 18.1% |
| Not reported | 267 | $29.7M | 61.2% |
Offers, award size, and timing
- Median reported offers
- 1 median
- 339 reported · 90 not reported
- Positive award obligations
- $33K median
- $3K–$104K middle 50%
- Reported performance period
- 256 days (~8 months) median
- 428 reported · 1 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Oct 23, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Top federal contractors
Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 20 of 97prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 15.4%of positive obligations in the last 12 months
- Leading four prime contractors
- 33.1%of positive obligations in the last 12 months
- Leading eight prime contractors
- 50.2%of positive obligations in the last 12 months
Based on $48.2M in positive obligations during the 12 months ending Oct 23, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Oct 24, 2024–Oct 23, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
15 leading contractors
- #1
Last 12mo obligations
$7.4M
15.4%
Dollar movement
+$322K
vs. prior 12 months
Last 12mo awards
17 awards
37 actions
Historical and award details for ROCHE DIAGNOSTICS CORPORATION
- Obligations: prior → latest
- $7.1M → $7.4M
- +4.5%
- Share: prior → latest
- 18.2% → 15.4%
- −2.8 percentage points
- All-period obligations
- $610.9M
- 11.2% of all-period positive obligations · 69 awards
- Recorded activity
- Since Oct 4, 2021
- through Apr 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 13 32 Not reported 4 8 Reported small business 0 0 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$3.8M
7.9%
Dollar movement
+$2.2M
vs. prior 12 months
Last 12mo awards
15 awards
22 actions
Historical and award details for HOLOGIC SALES AND SERVICE, LLC
- Obligations: prior → latest
- $1.6M → $3.8M
- +139.5%
- Share: prior → latest
- 4.1% → 7.9%
- +3.9 percentage points
- All-period obligations
- $14.9M
- 0.27% of all-period positive obligations · 52 awards
- Recorded activity
- Since Oct 6, 2021
- through Jun 3, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 15 24 Not reported 0 1 Reported small business 0 1 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$2.5M
5.2%
Dollar movement
+$950K
vs. prior 12 months
Last 12mo awards
17 awards
27 actions
Historical and award details for BECKMAN COULTER, INC
- Obligations: prior → latest
- $1.6M → $2.5M
- +60.1%
- Share: prior → latest
- 4.0% → 5.2%
- +1.2 percentage points
- All-period obligations
- $9.7M
- 0.18% of all-period positive obligations · 52 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 17 26 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$2.2M
4.6%
Dollar movement
+$1.1M
vs. prior 12 months
Last 12mo awards
9 awards
16 actions
Historical and award details for DIASORIN INC
- Obligations: prior → latest
- $1.1M → $2.2M
- +92.6%
- Share: prior → latest
- 2.9% → 4.6%
- +1.6 percentage points
- All-period obligations
- $5.3M
- 0.10% of all-period positive obligations · 28 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 2, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 8 14 Not reported 1 2 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$2.2M
4.5%
Dollar movement
+$1.4M
vs. prior 12 months
Last 12mo awards
4 awards
10 actions
Historical and award details for BIOFIRE DEFENSE LLC
- Obligations: prior → latest
- $758K → $2.2M
- +184.9%
- Share: prior → latest
- 1.9% → 4.5%
- +2.5 percentage points
- All-period obligations
- $8.1M
- 0.15% of all-period positive obligations · 21 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 3 Not reported 1 1 Reported small business 2 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$2.2M
4.5%
Dollar movement
+$1.8M
vs. prior 12 months
Last 12mo awards
4 awards
10 actions
Historical and award details for CEPHEID
- Obligations: prior → latest
- $396K → $2.2M
- +444.8%
- Share: prior → latest
- 1.0% → 4.5%
- +3.5 percentage points
- All-period obligations
- $9.5M
- 0.17% of all-period positive obligations · 23 awards
- Recorded activity
- Since Oct 13, 2021
- through Apr 6, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 6 Not reported 2 3 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$2.0M
4.1%
Dollar movement
−$490K
vs. prior 12 months
Last 12mo awards
18 awards
24 actions
Historical and award details for ABBOTT LABORATORIES INC.
- Obligations: prior → latest
- $2.5M → $2.0M
- −19.8%
- Share: prior → latest
- 6.3% → 4.1%
- −2.2 percentage points
- All-period obligations
- $14.3M
- 0.26% of all-period positive obligations · 69 awards
- Recorded activity
- Since Oct 14, 2021
- through Apr 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 18 24 Not reported 0 1 Reported small business 0 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$2.0M
4.0%
Dollar movement
−$123K
vs. prior 12 months
Last 12mo awards
28 awards
36 actions
Historical and award details for SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Obligations: prior → latest
- $2.1M → $2.0M
- −5.9%
- Share: prior → latest
- 5.3% → 4.0%
- −1.3 percentage points
- All-period obligations
- $609.8M
- 11.2% of all-period positive obligations · 278 awards
- Recorded activity
- Since Oct 4, 2021
- through Jun 30, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 10 15 Not reported 18 46 Reported small business 0 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$1.9M
4.0%
Dollar movement
+$1.7M
vs. prior 12 months
Last 12mo awards
17 awards
34 actions
Historical and award details for QUIDELORTHO SALES COMPANY, LLC
- Obligations: prior → latest
- $262K → $1.9M
- +632.8%
- Share: prior → latest
- 0.67% → 4.0%
- +3.3 percentage points
- All-period obligations
- $2.2M
- 0.040% of all-period positive obligations · 20 awards
- Recorded activity
- Since Jul 17, 2025
- through Jul 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 11 6 Not reported 6 1 Reported small business 0 0 All-period set-aside types
None reported.
- #10
Last 12mo obligations
$1.9M
3.9%
Dollar movement
+$318K
vs. prior 12 months
Last 12mo awards
12 awards
21 actions
Historical and award details for SYSMEX AMERICA, INC
- Obligations: prior → latest
- $1.6M → $1.9M
- +20.3%
- Share: prior → latest
- 4.0% → 3.9%
- −0.1 percentage points
- All-period obligations
- $7.9M
- 0.14% of all-period positive obligations · 26 awards
- Recorded activity
- Since Oct 12, 2021
- through Apr 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 12 17 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #11
Last 12mo obligations
$1.6M
3.3%
Dollar movement
+$497K
vs. prior 12 months
Last 12mo awards
4 awards
12 actions
Historical and award details for BECKMAN COULTER GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG
- Obligations: prior → latest
- $1.1M → $1.6M
- +45.0%
- Share: prior → latest
- 2.8% → 3.3%
- +0.5 percentage points
- All-period obligations
- $2.7M
- 0.050% of all-period positive obligations · 5 awards
- Recorded activity
- Since Sep 26, 2024
- through Mar 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 4 4 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$1.5M
3.2%
Dollar movement
+$1.4M
vs. prior 12 months
Last 12mo awards
1 award
2 actions
Historical and award details for ABBOTT MOLECULAR INC.
- Obligations: prior → latest
- $141K → $1.5M
- +982.1%
- Share: prior → latest
- 0.36% → 3.2%
- +2.8 percentage points
- All-period obligations
- $1.8M
- 0.030% of all-period positive obligations · 5 awards
- Recorded activity
- Since Feb 3, 2022
- through Feb 2, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 2 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$1.3M
2.6%
Dollar movement
+$734K
vs. prior 12 months
Last 12mo awards
21 awards
37 actions
Historical and award details for WERFEN USA LLC
- Obligations: prior → latest
- $519K → $1.3M
- +141.6%
- Share: prior → latest
- 1.3% → 2.6%
- +1.3 percentage points
- All-period obligations
- $2.5M
- 0.050% of all-period positive obligations · 44 awards
- Recorded activity
- Since Oct 13, 2021
- through Apr 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 12 14 Not reported 9 13 Reported small business 4 5 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$1.0M
2.1%
Dollar movement
+$694K
vs. prior 12 months
Last 12mo awards
3 awards
4 actions
Historical and award details for BIO RAD LABORATORIES INC
- Obligations: prior → latest
- $321K → $1.0M
- +216.3%
- Share: prior → latest
- 0.82% → 2.1%
- +1.3 percentage points
- All-period obligations
- $4.3M
- 0.080% of all-period positive obligations · 8 awards
- Recorded activity
- Since Oct 18, 2021
- through Feb 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 5 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$1.0M
2.1%
Dollar movement
+$197K
vs. prior 12 months
Last 12mo awards
8 awards
9 actions
Historical and award details for SUMMIT SHOJI INC.
- Obligations: prior → latest
- $807K → $1.0M
- +24.5%
- Share: prior → latest
- 2.1% → 2.1%
- 0.0 percentage points
- All-period obligations
- $4.6M
- 0.080% of all-period positive obligations · 63 awards
- Recorded activity
- Since Jan 12, 2022
- through Apr 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 8 11 Reported small business 0 0 All-period set-aside types
None reported.
Recent federal contract award activity
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
Modification
This action
+$857K
HOLOGIC SALES AND SERVICE, LLC
NAVMEDCEN CAMP LEJEUNE NC - MM
HOLOGIC TEST KITS (COVID)
Why it stands out
The contractor climbed 2 positions in this market.
It now ranks #2 by positive obligations over the latest 12 months.
- Award net obligations
- $3.0M
- Share of 12-month positive obligations
- 1.8%
Supporting data
- Prime contractor
- #2 · 7.9% share
- up 2 ranks · +3.9 percentage points · $2.2M net increase; action accounted for 38.4%
- Funding office
- #15 · 2.0% attributed share
- +2.0 percentage points · $960K net increase; action accounted for 89.3%
Related:Largest share gain
Modification
This action
+$1.4M
ROCHE DIAGNOSTICS CORPORATION
AMC TRIPLER SHAFTER - MM
ROCHE DIAGNOSTICS CLINICAL CHEMISTRY AND IMMUNOASSAY REAGENTS AND ANALYZERS FOR TRIPLER ARMY MEDICAL CENTER, HI.
Why it stands out
The award grew alongside stronger office-attributed spending.
The modification added $1.4M while office-attributed obligations rose $1.4M overall.
- Award net obligations
- $2.9M
- Share of 12-month positive obligations
- 2.9%
Supporting data
- Funding office
- #3 · 7.0% attributed share
- up 1 rank · +2.5 percentage points · $1.4M net increase; action exceeded it by $40K
Modification
This action
+$1.5M
ABBOTT MOLECULAR INC.
AMC BAMC FSH - MM
FOR MOLECULAR TRANSPLANT, RESPIRATORY, AND SEXUAL HEALTH TESTING DEPARTMENT OF PATHOLOGY AND AREA LABORATORY SERVICES
Why it stands out
The contractor climbed 39 positions in this market.
It now ranks #12 by positive obligations over the latest 12 months.
- Award net obligations
- $1.5M
- Share of 12-month positive obligations
- 3.2%
Supporting data
- Prime contractor
- #12 · 3.2% share
- up 39 ranks · +2.8 percentage points · $1.4M net increase; action exceeded it by $141K
Related:Largest rank gain
Modification
This action
+$1.5M
BECKMAN COULTER, INC
ACH BENNING - MM
RELEASE OF FY26 FUNDS
Why it stands out
The contractor climbed 2 positions in this market.
It now ranks #3 by positive obligations over the latest 12 months.
- Award net obligations
- $1.5M
- Share of 12-month positive obligations
- 3.1%
Supporting data
- Prime contractor
- #3 · 5.2% share
- up 2 ranks · +1.2 percentage points · $950K net increase; action exceeded it by $544K
Modification
This action
+$665K
ORTHO-CLINICAL DIAGNOSTICS SINGAPORE PTE. LTD. KOREA BRANCH
ACH BRIAN ALLGOOD - PA
REAGENTS TO INCLUDE CHEMISTRY/IMMUNOLOGY ANALYZERS FOR BDAACH, KOREA
Why it stands out
The contractor climbed 35 positions in this market.
It now ranks #17 by positive obligations over the latest 12 months.
- Award net obligations
- $2.0M
- Share of 12-month positive obligations
- 1.4%
Supporting data
- Prime contractor
- #17 · 1.9% share
- up 35 ranks · +1.5 percentage points · $770K net increase; action accounted for 86.4%
- Funding office
- #7 · 3.1% attributed share
- +3.1 percentage points · $2.2M net increase; action accounted for 30.5%
Modification
This action
+$1.4M
CEPHEID
AMC BAMC FSH - MM
FY26 COVID AND STREP TESTING. REAL TIME POLYMER CHAIN REACTION (RT-PCR) ANALYZERS FOR BROOKE ARMY MEDICAL CENTER
Why it stands out
The contractor climbed 23 positions in this market.
It now ranks #6 by positive obligations over the latest 12 months.
- Award net obligations
- $1.1M
- Share of 12-month positive obligations
- 2.9%
Supporting data
- Prime contractor
- #6 · 4.5% share
- up 23 ranks · +3.5 percentage points · $1.8M net increase; action accounted for 78.1%
View recent award activity by date (10)
- Action−$84KAward net obligations$541K
- Action+$23Award net obligations$23
- Action+$32KAward net obligations$541K
- Action+$13KAward net obligations$13K
- Action+$109KAward net obligations$109K
- Action+$5KAward net obligations$80K
- Action+$846Award net obligations$846
- Action+$424Award net obligations$424
- Action+$42Award net obligations$42
- Action+$304KAward net obligations$304K
DoD in-vitro diagnostic substance manufacturing market FAQs
Answers based on reported federal contract data.
Who are the top DoD in-vitro diagnostic substance manufacturing contractors?
In the 12 months through October 23, 2026, ROCHE DIAGNOSTICS CORPORATION, HOLOGIC SALES AND SERVICE, LLC, and BECKMAN COULTER, INC were the leading DoD in-vitro diagnostic substance manufacturing prime contractors by positive obligations.
- #1
$7,423,744 in positive obligations
- #2
HOLOGIC SALES AND SERVICE, LLC
$3,828,560 in positive obligations
- #3
$2,528,806 in positive obligations
Rankings use reported USAspending award data.
Did DoD contract obligations increase in the in-vitro diagnostic substance manufacturing market?
Yes. Measured by net prime contract obligations, reported DoD activity in the in-vitro diagnostic substance manufacturing market increased 25.3% from $38,331,741 in the preceding 12 months to $48,043,595 in the 12 months through October 23, 2026.
- Latest 12 months
- $48,043,595
- Net prime contract obligations
- Preceding 12 months
- $38,331,741
- Net prime contract obligations
- Change
- +25.3%
- Between matched 12-month periods
Reported contract actions, not outlays or a forecast.
What recent DoD contract award activity was reported in the in-vitro diagnostic substance manufacturing market?
Recent DoD contract award activity reported in the in-vitro diagnostic substance manufacturing market included actions for HOLOGIC SALES AND SERVICE, LLC, ROCHE DIAGNOSTICS CORPORATION, and ABBOTT MOLECULAR INC. during the 12 months through October 23, 2026.
-
HOLOGIC SALES AND SERVICE, LLC · PIID HT940624P0005
Modification P00004 · December 8, 2025 · Action obligation: +$857,260
-
ROCHE DIAGNOSTICS CORPORATION · PIID W81K0222P0104
Modification P00018 · January 27, 2026 · Action obligation: +$1,415,436
-
ABBOTT MOLECULAR INC. · PIID W81K0025CA008
Modification P00001 · December 3, 2025 · Action obligation: +$1,521,794
-
BECKMAN COULTER, INC · PIID W81K0025PA174
Modification P00002 · December 11, 2025 · Action obligation: +$1,493,318
-
ORTHO-CLINICAL DIAGNOSTICS SINGAPORE PTE. LTD. KOREA BRANCH · PIID W81K0223P0026
Modification P00009 · December 10, 2025 · Action obligation: +$664,785
-
CEPHEID · PIID W81K0025FA081
Modification P00002 · December 8, 2025 · Action obligation: +$1,373,683
Action obligations are transaction-level amounts, not current award-level obligations.
Which procurement methods were reported for DoD contracts under NAICS 325413?
From October 24, 2025 through October 23, 2026, DoD reported 429 positive-obligation awards for in-vitro diagnostic substance manufacturing under NAICS 325413. The leading award type was purchase order. The leading reported procedure was simplified acquisition.
- Positive-obligation awards
- 429
- Leading reported procedure
- Simplified Acquisition
- 73.7% of positive obligations
- Leading award type
- Purchase Order
- 48.6% of positive obligations
- Full and open
- 10%
- of positive obligations
- Reported parent IDV
- 38.8%
- of positive obligations
Percentages use positive obligations as the denominator.
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Reported obligations include contract actions from October 1, 2021 through October 23, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.
Review data methodology